Thus, in the current study, we sought to investigate the potential role of ADAM6 and PRSS1 in leukemogenesis as well as their potential as diagnostic and/or prognostic biomarkers in adult patients with ALL and AML. Here, ADAM6 is linked to acute myeloid leukemia.